Myriad Genetics Inc (NASDAQ:MYGN)

34.96
Delayed Data
As of Feb 26
 -0.46 / -1.30%
Today’s Change
31.56
Today|||52-Week Range
42.50
+2.64%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Evans James S
Chief Financial Officer
Sale4/02/201476,139$40.00$3.0M-10.77%
Evans James S
Chief Financial Officer
Sale9/23/201475,864$38.08$2.9M-7.71%
Evans James S
Chief Financial Officer
Buy4/02/201476,139$30.34$2.3M-10.77%
Evans James S
Chief Financial Officer
Buy9/23/201475,864$30.12$2.3M-7.71%
Meldrum Peter D
President & Chief Executive Officer
Sale4/02/201455,000$39.57$2.2M-10.77%
Lanchbury Jerry S
Chief Scientific Officer
Sale4/02/201454,676$39.65$2.2M-10.77%
Meldrum Peter D
President & Chief Executive Officer
Sale3/19/201455,000$37.00$2.0M-2.81%
Meldrum Peter D
President & Chief Executive Officer
Sale3/17/201455,000$35.15$1.9M-0.11%
Marsh Richard M
Executive Vice President & General Counsel
Sale3/12/201450,000$34.37$1.7M-0.65%
Meldrum Peter D
President & Chief Executive Officer
Buy3/17/201455,000$30.12$1.7M-0.11%
Page of 10

To view my watchlist

Not a member yet?

Sign up now for a free account